查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1182112

細胞因子全球市場規模研究與預測：按細胞因子類型、治療用途、區域分析，2022-2029 年

Global Cytokine Market Size study & Forecast, by Cytokine Type, Therapeutic Application, and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

細胞因子是體內各種細胞釋放的細胞信號分子。

細胞因子是調節多種生理和代謝過程的蛋白質，是細胞間通訊的重要手段。 市場受到主要因素的推動，例如傷口管理對細胞因子的需求不斷增加以及癌症研究的資金增加。

根據 Globocan 2020，登記了 19,292,789 例新癌症病例。 到 2040 年，這個數字預計將達到 28,887,940。 此外，2022 年 4 月，在美國癌症研究協會 (AACR) 2022 年年會上，開發靶向免疫療法的臨床階段公司 Sonnet BioTherapeutics Holdings, Inc. 宣布其獲得專利的全人白蛋白我們正在展示臨床前研究的數據關於綁定候選 SON-1010、SON-1210 和 SON-1410。 然而，高昂的處理成本阻礙了整個 2022-2029 年預測期內的市場增長。

全球細胞因子市場研究中考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於競爭對手的存在、併購、研究資金的收購以及該地區癌症患病率上升，北美在全球市場份額中處於領先地位。 然而，由於政府研發支出的增加和製藥公司的增加，預計亞太地區將成為增長最快的地區。

本研究的目的是闡明近年來各個細分市場和國家/地區的市場規模，並預測未來幾年的市場規模。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還包含供利益相關者投資的微觀市場潛在機會，以及對主要參與者的競爭格局和產品供應的深入分析。

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年各細分市場的全球市場估計和預測
    • 2019-2029 年按地區劃分的細胞因子市場
    • 細胞因子市場：按細胞因子類型分類，2019-2029
    • 細胞因子市場：按治療用途分類，2019-2029 年
  • 主要趨勢
  • 調查方法介紹
  • 調查先決條件

第 2 章全球細胞因子市場定義和範圍

  • 調查的目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 調查年份
  • 貨幣兌換率

第 3 章全球細胞因子市場動態

  • 細胞因子市場影響分析 (2019-2029)
    • 市場驅動因素
      • 傷口處理對細胞因子的需求不斷擴大
      • 擴大對癌症研究的資助
    • 市場挑戰
      • 飆升的治療費用
    • 市場機會
      • 啟動研發活動
      • 增加基於細胞培養的研究活動

第四章全球細胞因子市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 投資招聘模式
  • 分析師的結論和建議
  • 頂級投資機會
  • 關鍵成功策略

第 5 章風險評估：COVID-19 的影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球細胞因子市場，按細胞因子類型分類

  • 市場概況
  • 全球細胞因子市場：按細胞因子類型進行性能潛力分析
  • 2019-2029 年按細胞因子類型劃分的世界細胞因子市場、估計和預測
  • 細胞因子市場、細分市場分析
    • 腫瘤壞死因子 (TNF)
    • 白細胞介素-Il
    • 干擾素-IFN
    • 表皮生長因子-EGF
    • 其他細胞因子類型

第 7 章全球細胞因子市場：按治療用途分類

  • 市場概況
  • 全球細胞因子市場：按治療用途分類的性能和潛力分析
  • 世界細胞因子市場、按治療用途估計和預測 (2019-2029)
  • 全球細胞因子市場細分分析
    • 癌症
    • 支氣管哮喘和氣道炎症
    • 關節炎
    • 其他治療用途

第 8 章全球細胞因子市場：區域分析

  • 細胞因子市場，區域市場概況
  • 北美
    • 美國
      • 按細胞因子類型估算和預測，2019-2029 年
      • 2019-2029 年治療用途的估計和預測
    • 加拿大
  • 歐洲細胞因子市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲地區
  • 亞太地區細胞因子市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲細胞因子市場概況
    • 巴西
    • 墨西哥
  • 世界其他地區

第 9 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • AstraZeneca plc
      • 主要信息
      • 概覽
      • 財務信息（取決於數據可用性）
      • 產品概述
      • 近期趨勢
    • GlaxoSmithkline PLC
    • Johnson and Johnson
    • Pfizer Inc.
    • Novartis AG
    • Biocon Limited
    • Amgen Inc.
    • Sanofi SA
    • UCB S.A
    • AbbVie Inc.

第 10 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查屬性
  • 調查先決條件

Global Cytokine Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.2% over the forecast period 2022-2029. Cytokines are cell signalling molecules that are released by various bodily cells. Cytokines are proteins that regulate a variety of physiological and metabolic processes and serve as a vital form of cell contact. The market is majorly driven by key factors such as the growing demand for cytokines for wound management and growing funding for cancer-based research.

According to Globocan 2020, 19,292,789 new cancer cases were registered. By 2040, this number is anticipated to reach 28,887,940. Additionally, in April 2022, at the American Association for Cancer Research (AACR) Annual Meeting 2022, Sonnet BioTherapeutics Holdings, Inc., a clinical-stage firm developing targeted immunotherapeutic medicines, presented data from preclinical research on the company's patented Fully Human Albumin Binding candidates, SON-1010, SON-1210, and SON-1410. However, high costs for Therapy stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Cytokine Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is leading the global market shares owing to the presence of competitors, mergers, acquisitions and research funding and the rising prevalence of cancer in the region. However, Asia Pacific is expected to be the fastest growing region owing to growing research and development funding from the government and an increasing number of pharmaceutical manufacturers.

Major market players included in this report are:

AstraZeneca plc

GlaxoSmithkline PLC

Johnson and Johnson

Pfizer Inc.

Novartis AG

Biocon Limited

Amgen Inc.

Sanofi SA

UCB S.A

AbbVie Inc.

Recent Developments in the Market:

  • In July 2020, Derm-Biome Pharmaceutical and Pan-Biome Pharmaceutical stated that they had secured a pre-seed investment of US$ 500,000 to create drugs for the treatment of chronic inflammatory illnesses, including cytokines that reduce inflammation.
  • A contract for the development and production of the medication Lenzilumab was signed in January 2021 by Emergent BioSolutions and Humanigen. This medication is intended to both prevent and treat an immunological hyper-reaction to the cytokine storm.

Global Cytokine Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Cytokines type, Therapeutics Application, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Cytokines Type:

Tumor Necrosis Factor-TNF

Interleukins-Il

Interferons-IFN

Epidermal Growth Factor-EGF

Other Cytokine Types

By Therapeutic Application:

Cancer

Asthma and Airway Inflammation

Arthritis

Other Therapeutic Applications

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Cytokine Market, by region, 2019-2029 (USD Billion)
    • 1.2.2. Cytokine Market, by Cytokine Type, 2019-2029 (USD Billion)
    • 1.2.3. Cytokine Market, by Therapeutic Application, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cytokine Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cytokine Market Dynamics

  • 3.1. Cytokine Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing demand for cytokines for wound management
      • 3.1.1.2. Growing funding for cancer-based research
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Costs for Therapy
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing research and development activities
      • 3.1.3.2. Growing cell culture-based research activities

Chapter 4. Global Cytokine Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Cytokine Market, by Cytokine Type

  • 6.1. Market Snapshot
  • 6.2. Global Cytokine Market by Cytokine Type, Performance - Potential Analysis
  • 6.3. Global Cytokine Market Estimates & Forecasts by Cytokine Type 2019-2029 (USD Billion)
  • 6.4. Cytokine Market, Sub Segment Analysis
    • 6.4.1. Tumor Necrosis Factor-TNF
    • 6.4.2. Interleukins-Il
    • 6.4.3. Interferons-IFN
    • 6.4.4. Epidermal Growth Factor-EGF
    • 6.4.5. Other Cytokine Types

Chapter 7. Global Cytokine Market, by Therapeutic Application

  • 7.1. Market Snapshot
  • 7.2. Global Cytokine Market by Therapeutic Application, Performance - Potential Analysis
  • 7.3. Global Cytokine Market Estimates & Forecasts by Therapeutic Application 2019-2029 (USD Billion)
  • 7.4. Cytokine Market, Sub Segment Analysis
    • 7.4.1. Cancer
    • 7.4.2. Asthma and Airway Inflammation
    • 7.4.3. Arthritis
    • 7.4.4. Other Therapeutic Applications

Chapter 8. Global Cytokine Market, Regional Analysis

  • 8.1. Cytokine Market, Regional Market Snapshot
  • 8.2. North America Cytokine Market
    • 8.2.1. U.S. Cytokine Market
      • 8.2.1.1. Cytokine Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Therapeutic Application breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Cytokine Market
  • 8.3. Europe Cytokine Market Snapshot
    • 8.3.1. U.K. Cytokine Market
    • 8.3.2. Germany Cytokine Market
    • 8.3.3. France Cytokine Market
    • 8.3.4. Spain Cytokine Market
    • 8.3.5. Italy Cytokine Market
    • 8.3.6. Rest of Europe Cytokine Market
  • 8.4. Asia-Pacific Cytokine Market Snapshot
    • 8.4.1. China Cytokine Market
    • 8.4.2. India Cytokine Market
    • 8.4.3. Japan Cytokine Market
    • 8.4.4. Australia Cytokine Market
    • 8.4.5. South Korea Cytokine Market
    • 8.4.6. Rest of Asia Pacific Cytokine Market
  • 8.5. Latin America Cytokine Market Snapshot
    • 8.5.1. Brazil Cytokine Market
    • 8.5.2. Mexico Cytokine Market
  • 8.6. Rest of The World Cytokine Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. AstraZeneca plc
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. GlaxoSmithkline PLC
    • 9.2.3. Johnson and Johnson
    • 9.2.4. Pfizer Inc.
    • 9.2.5. Novartis AG
    • 9.2.6. Biocon Limited
    • 9.2.7. Amgen Inc.
    • 9.2.8. Sanofi SA
    • 9.2.9. UCB S.A
    • 9.2.10. AbbVie Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Cytokine Market, report scope
  • TABLE 2. Global Cytokine Market estimates & forecasts by region 2019-2029 (USD Billion)
  • TABLE 3. Global Cytokine Market estimates & forecasts by Cytokine Type 2019-2029 (USD Billion)
  • TABLE 4. Global Cytokine Market estimates & forecasts by Therapeutic Application 2019-2029 (USD Billion)
  • TABLE 5. Global Cytokine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Cytokine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Cytokine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Cytokine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Cytokine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Cytokine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Cytokine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Cytokine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Cytokine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Cytokine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Cytokine Market
  • TABLE 70. List of primary sources, used in the study of global Cytokine Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Cytokine Market, research methodology
  • FIG 2. Global Cytokine Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Cytokine Market, key trends 2021
  • FIG 5. Global Cytokine Market, growth prospects 2022-2029
  • FIG 6. Global Cytokine Market, porters 5 force model
  • FIG 7. Global Cytokine Market, pest analysis
  • FIG 8. Global Cytokine Market, value chain analysis
  • FIG 9. Global Cytokine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Cytokine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Cytokine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Cytokine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Cytokine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Cytokine Market, regional snapshot 2019 & 2029
  • FIG 15. North America Cytokine Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Cytokine Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Cytokine Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Cytokine Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Cytokine Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable